This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Simcere Pharmaceutical Co., Ltd, Simcere Bio-Pharmaceutical Technology., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Xinyan Zhao: Innovator in Immune-Related Therapeutics
Introduction
Xinyan Zhao is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies. His research focuses on developing therapeutic solutions for immune-related disorders.
Latest Patents
Xinyan Zhao holds a patent for an "Anti-TNFR2 antibody and use thereof." This invention provides an antibody or an antigen-binding fragment capable of specifically binding to TNFR2. The antibody is designed to regulate the function of immune cells and may be utilized as a medicament to treat diseases related to immune-related disorders, such as tumors. Additionally, the patent includes a polynucleotide encoding the antibody and a pharmaceutical composition comprising the antibody or antigen-binding fragment.
Career Highlights
Throughout his career, Xinyan Zhao has worked with notable companies in the pharmaceutical industry. He has been associated with Jiangsu Simcere Pharmaceutical Co., Ltd and Simcere Bio-Pharmaceutical Technology, Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic applications.
Collaborations
Xinyan Zhao has collaborated with several professionals in his field, including Ran Pang and Shiqiang Lu. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Xinyan Zhao's contributions to immunology through his patented inventions highlight his role as a key innovator in the field. His work continues to pave the way for new therapeutic approaches to combat immune-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile